Sanofi chooses Swansea as UKs pioneer Diabetes Centre of Excellence
Category: #health  By Saipriya Iyer  Date: 2018-05-25
  • share
  • Twitter
  • Facebook
  • LinkedIn

Sanofi chooses Swansea as UKs pioneer Diabetes Centre of Excellence

Sanofi S.A., a French pharma company, has joined hands with the UK-based Swansea University Medical School, opting for the organization to be the country’s first Diabetes Centre of Excellence. Sanofi has chosen the JCRF (Joint Clinical Research Facility) of the Medical school along with Cymru, Swansea’s diabetes research establishment.

Reportedly, UK’s reputed medical school had already worked with the pharma giant on several critical projects. However, it has been chosen by Sanofi after JCRF repeatedly exhibited its capability to provide excellent services to its customers. For the record, JCRF is the combined entity of Swansea University Medical School & Abertawe Bro Morgannwg University Health Board.

Prof. Steve Bain, the Clinical Lead for the Diabetes Research Unit at Cymru, has stated that the university is looking forward to working on the drug product portfolio in collaboration with Sanofi S.A. Professor Keith Lloyd, the Dean of Swansea, has also reportedly emphasized that the high-quality R&D activities carried out in the field of diabetes at Swansea University will help in tackling the current healthcare issues related to diabetes.

As per Victoria DiBiaso, Global Head of Clinical Operations Strategy & Collaboration at Sanofi, the goal of the collaboration of Sanofi & Swansea is aimed at utilizing JCRF’s knowledge related to diabetes research in clinical tests conducted by Sanofi. She further added that establishing liaisons with reputed research organizations working on diabetes will assist the firm in carrying out medical trials effectively. Experts familiar with the matter claim that the collaboration may prove to be highly beneficial for diabetic patients in the near future.

Sanofi joint venture with the based Swansea University Medical School is speculated to address the social & healthcare requirements of diabetics and explore key areas in diabetes research. Analysts have projected that the partnership will help in fulfilling the unmet medical requirements of patients in addition to supporting the economic growth in Wales.



About Author

Saipriya Iyer

Email: [email protected]   

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

Read More

More News By Saipriya Iyer

Vela Diagnostics gains EUA for ViroKey™ SARS-CoV-2 RT-PCR test v2.0
Vela Diagnostics gains EUA for ViroKey™ SARS-CoV-2 RT-PCR test v2.0
By Saipriya Iyer

Vela Diagnostics has recently announced that the U.S. FDA has granted an EUA (Emergency Use Authorization) for its ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 in the United States. This automated p...

Foodics enters Egypt market by setting an on-ground presence in Cairo
Foodics enters Egypt market by setting an on-ground presence in Cairo
By Saipriya Iyer

Saudi Arabia-based restaurant management platform Foodics, has announced that it has entered the Egyptian market by creating an on-the-ground presence in Cairo.  The expansion comes after the company raised USD 4 ...

Food Emulsifiers Market to Witness an Appreciable Growth By 2026
Food Emulsifiers Market to Witness an Appreciable Growth By 2026
By Saipriya Iyer

This advanced report on the Food Emulsifiers Market includes of an in-depth overview of this business sphere. Alongside, details of the present market size and status have been given. The report aims to provide substantial updates on the market, p...